Delivery Order SPE2DB22D3501-SPE2DB25FXF74
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,641.05 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules. This competitive award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.56 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,369.77 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nexium DR 40 mg capsules (90-count unit) with a ceiling value of $5,138.14. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,644.69 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitive award utilizes firm fixed-price pricing with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for NEXIUM DR 20 mg capsules (90-count) valued at $1,299.08 under a firm fixed-price contract type. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Nexium DR 40 mg capsules (30-count packages) with a ceiling value of $2,250.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a $2,351.58 delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules. This firm fixed-price contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a direct delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The contract utilizes no set-aside designation and was awarded competitively. Performance will occur at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 12, 2025. The order, valued at $2,064.24 with a firm fixed price structure, is for 90-count bottles of Nexium DR 40 mg capsules. This is a non-set-aside competitive award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF74Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,317.28 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, issued on September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA prime contract encompasses a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, enabling delivery of brand-name and generic medications, vaccines, and specialized medical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. This specific delivery order for Nexium represents a routine pharmaceutical supply transaction under the larger strategic pharmaceutical prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/9/25 |